Otc - Active Ingredient
niacinamide
Karatica I M Cure
FDA Label NDC 70514-0012
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Karatica Co., Ltd for the product Karatica I M Cure (NDC 70514-0012). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
SodiumHyaluronate, Niacinamide, CamelliaJaponicaFlowerExtract, CentellaAsiaticaExtract, Tranexamicacid, SalicylicAcid, TetraPeptide-44, Sh-Oligopepide-1, Sh-Polypepide-1
Otc - Purpose
skin soothing and care
Otc - Keep Out Of Reach Of Children
keep out or reach of the children
Indications & Usage
Clean and dry the face. Apply the patch on the troubled area and press it gently for 10 seconds. Leave the patch on for 2‒3 hours.
* The Essence Chip (micro projections) must be kept dry.
Warnings
1) Discontinue use or consult dermatologist if irritation, itching or swelling appears after appying the product.
2) Avoid applying patches on the wounded, inflamed skin parts.
3) Cautions for the storage and handling.
- Keep out of children.
- Avoid applying around eyes.
Dosage & Administration
for external use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
